Anthocyanin
Anthocyanin is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Glycaemic Index (GI) Evaluation of Carbohydrate-based Food with Functional Ingredients Derived from Food Sources
Anthocyanin Dose-escalation Study in Healthy Young Adults
Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins
Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment
Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function
Clinical Trials (8)
Glycaemic Index (GI) Evaluation of Carbohydrate-based Food with Functional Ingredients Derived from Food Sources
Anthocyanin Dose-escalation Study in Healthy Young Adults
Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins
Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment
Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function
Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus
Purified Anthocyanin and Nonalcoholic Fatty Liver Disease
Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8